GIKLY : Summary for GRIFOLS SA SPON ADR EA REPR 1/2 - Yahoo Finance

U.S. Markets closed

Grifols, S.A. (GIKLY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
12.260.00 (0.00%)
At close: 9:54AM EDT
People also watch
GASNYEBRPYIDEXYGNGBYGCTAY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close12.26
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume120
Market Cap15.74B
Beta0.44
PE Ratio (TTM)28.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.19 (1.58%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals4 days ago

    Can young blood pump new life into treatments for diseases of aging?

    Young blood loaded with a particular protein, which is less plentiful as people age, could rejuvenate learning and memory, Stanford University researchers said in a paper released today. It would take even longer to make drugs that mimic the protein. Ultimately, San Carlos' Alkahest Inc., which has rights to license the research, and Barcelona-based Grifols S.A. (GRFS) could market treatments aimed at age-associated declines in learning skills and memory, but not necessarily targeting memory-robbing Alzheimer's disease.

  • Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program
    PR Newswire6 days ago

    Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program

    BARCELONA, Spain, April 17, 2017 /PRNewswire/ -- Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next five (5) years. This announcement is a continuation of the Company's three-year commitment from 2014, bringing the total humanitarian aid commitment to more than 200M IU of Factor VIII over eight years.

  • Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program
    PR Newswire6 days ago

    Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program

    BARCELONA, Spain, April 17, 2017 /PRNewswire/ -- Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next five (5) years. This announcement is a continuation of the Company's three-year commitment from 2014, bringing the total humanitarian aid commitment to more than 200M IU of Factor VIII over eight years.